Table III.
Cause-specific survival for the patients with Kaposi’s sarcoma in the time periods derived from Jointpoint analysis
| Period of Diagnosis | Months since diagnosis | Non-Hispanic Whites % survival (95%CI) | African-Americans % survival (95% CI) |
|---|---|---|---|
| 1973-80 | 12 | 93.5 (89.3-96.1) | 100.0† |
| 60 | 89.9 (84.9-93.3) | 100.0† | |
| 1981-84 | 12 | 86.8 (83.6-89.4) | 84.1 (67.9-92.5) |
| 60 | 52.2 (46.7-57.3) | 56.6 (35.0-73.5) | |
| 1985-88 | 12 | 71.0 (69.0-73.0) | 59.6 (51.2-67.1) |
| 60 | 16.5 (14.7-18.4) | 21.0 (14.5-28.3) | |
| 1989-93 | 12 | 67.6 (65.9-69.3) | 58.6 (53.8-63.1) |
| 60 | 15.3 (13.9-16.7) | 15.7 (12.3-19.4) | |
| 1994-97 | 12 | 70.8 (68.3-73.1) | 59.7 (54.3-64.6) |
| 60 | 45.0 (42.2-47.7) | 38.3 (33.1-43.5) | |
| 1998-2013 | 12 | 87.9 (86.1-89.4) | 72.5 (69.2-75.6) |
| 60 | 78.7 (76.4-80.8) | 57.9 (54.1-61.5) |
†Subgroup analysis not done